Mixed Chimeric Transplantation for Primary Amyloidosis
To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.
Amyloidosis
PROCEDURE: autologous followed by nonmyeloablative allogeneic transplant
Treatment of patients with nonmyeloablative allogeneic transplant for amyloidosis.
Toxicity of therapy|Changes in marrow and serum abnormalities|Improvement in end-organ function.
To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.